Galantamine (Razadyne)

What it treats

Galantamine is approved by the U.S. Food and Drug Administration for mild to moderate Alzheimer's disease dementia. Unlike donepezil, it doesn't carry an approval for severe Alzheimer's, and unlike rivastigmine it doesn't have a specific Parkinson's dementia approval.

It's occasionally used off-label in vascular dementia and mixed dementia. In practice, when a clinician reaches for a cholinesterase inhibitor for Alzheimer's, the choice between donepezil, rivastigmine patch, and galantamine is usually driven by tolerability and cost more than a clear efficacy difference.

How it works

Galantamine has two mechanisms, and both matter.

First, like donepezil and rivastigmine, it blocks acetylcholinesterase, so more acetylcholine is available at nerve endings.

Second, it acts as an allosteric modulator at nicotinic acetylcholine receptors. Rather than turning the receptor on directly, it changes the shape of the receptor so that the acetylcholine that's there produces a bigger response. Whether this second mechanism translates to a meaningful clinical difference is genuinely uncertain. It's a plausible reason some people respond to galantamine when they haven't done well on donepezil, but the head-to-head data isn't strong.

Receptor mechanism (detail)

Galantamine is a reversible, competitive inhibitor of acetylcholinesterase (AChE) and a positive allosteric modulator of nicotinic acetylcholine receptors. That combination raises available acetylcholine and makes the remaining nicotinic receptors more responsive to it. Downstream effects at muscarinic and nicotinic receptors are the same class-level story: cognitive effects centrally, GI and cardiac effects peripherally.

Potency and typical dosing pattern

Ranges are typical framework only, not a prescription for any individual.

Extended-release (Razadyne ER) is the more commonly used form. Start 8 mg once daily in the morning with food. After 4 weeks, if tolerated, step up to 16 mg once daily. After another 4 weeks, if needed and tolerated, step up to 24 mg once daily. Target maintenance is 16 to 24 mg once daily.

Immediate-release tablets are dosed twice daily following a similar pattern (4 mg BID, then 8 mg BID, then 12 mg BID). The ER form is preferred for adherence.

Take with a full meal and adequate fluids. Empty-stomach dosing meaningfully worsens nausea.

Safety monitoring

• Heart rate and rhythm. Class-level slowing. Baseline pulse and a low threshold for an ECG in people with conduction disease or on rate-slowing drugs.
• Weight and appetite. Track at every visit. Weight loss is a real problem in this population.
• GI symptoms. Nausea, vomiting, diarrhea, and appetite loss in the first weeks after each dose step.
• Renal and hepatic function. Dose adjustment is needed in moderate renal or hepatic impairment. Not recommended in severe impairment.
• Falls and syncope. New falls, dizziness, or fainting need a look at the drug.
• Interruptions in therapy. If dosing is missed for more than 3 days, restart at the lowest dose and titrate back up. Restarting at the maintenance dose is a set-up for severe GI toxicity.

What to expect

Effect emerges gradually over 3 to 6 months as a slower rate of decline. Families sometimes notice better attention, engagement, or word-finding compared to what they were expecting. Formal scores drift down more slowly than they would without treatment. It's a stabilization drug, not a rescue.

GI side effects, if they come, show up in the first weeks after starting or stepping up the dose. Taking it with food and titrating slowly are the main tools to manage them. Some people do fine on 16 mg and never need to push to 24 mg.

Common side effects

Most common side effects are GI, especially in the first weeks.

• Nausea.
• Vomiting.
• Diarrhea.
• Loss of appetite and weight loss.
• Dizziness.
• Headache.
• Fatigue.
• Insomnia or vivid dreams.

Slow titration and taking the dose with food are the main ways to reduce these. Most ease after the first couple of weeks at a given dose step.

Serious side effects and warnings

• Bradycardia and syncope. Additive with beta blockers, verapamil, diltiazem, and digoxin. Fainting is a reason to stop and reassess.
• Severe GI toxicity on restart. If therapy has been off for more than 3 days, restarting at the maintenance dose can cause severe vomiting and dehydration. Always restart low.
• GI bleeding. Higher risk with NSAIDs or a history of ulcer.
• Weight loss. Progressive weight loss is a real concern in older adults.
• Serious skin reactions. Stevens-Johnson syndrome and acute generalized exanthematous pustulosis have been reported. Rash needs urgent attention.
• Seizures. Rare but reported.
• Urinary obstruction in people with existing bladder outlet issues.

Sexual and relational effects

Sexual side effects with galantamine aren't a common complaint. The bigger relational impact is the same story as with the other cholinesterase inhibitors: care partners are hoping for the person to "come back," and the honest answer is that the drug can slow the slope of decline and sometimes bring back a modest amount of engagement for a while. That's the win to look for.

Weight, appetite, and sleep

Weight loss can be a real problem. Appetite often dips at each dose step and doesn't always fully return. Track weight at every visit and consider supplemental nutrition if the trend is meaningful.

Sleep effects usually tilt toward vivid dreams or occasional insomnia. Because galantamine is dosed in the morning, sleep is less commonly a limiting factor than with bedtime donepezil.

Starting and dosing basics

This section is general background, not a dosing instruction for any individual. The right dose is a decision for a prescriber.

Galantamine ER capsules come in 8, 16, and 24 mg. Immediate-release tablets come in 4, 8, and 12 mg. There's also an oral solution. The ER form is generally preferred for once-daily dosing.

Take in the morning with a full meal and adequate fluids. Titrate slowly, at least 4 weeks between dose steps, longer if side effects are marginal.

Missed doses and interactions

If a single dose is missed, take the next dose at the usual time. Don't double up. If more than 3 consecutive days have been missed, contact the prescriber before restarting; the dose usually needs to be walked back up from the beginning.

Interactions that matter:

• Beta blockers, verapamil, diltiazem, digoxin. Additive bradycardia.
• Anticholinergics. Diphenhydramine, oxybutynin, older tricyclics, and similar drugs oppose galantamine. Common problem in older adults.
• NSAIDs. Higher GI bleeding risk.
• Strong CYP3A4 or CYP2D6 inhibitors (paroxetine, fluoxetine, ketoconazole, erythromycin) raise galantamine levels and can worsen side effects.
• Succinylcholine. Prolonged neuromuscular blockade during anesthesia.

Give every prescriber a full medication list, including over-the-counter drugs.

Stopping and tapering

Galantamine doesn't cause a classic withdrawal, but stopping is often followed by a step-down in cognition or function that may not recover on restart. If the plan is to stop, tapering down over several weeks and watching for a change is safer than a hard stop.

Reasons to stop include intolerable side effects, disease so advanced the drug is no longer providing meaningful benefit, and end-of-life care. Decisions like this belong with the family, the patient (where possible), and the prescriber.

Pregnancy and breastfeeding

This isn't a routine issue given the patient population. Galantamine isn't used in pregnancy or breastfeeding in ordinary practice. Anyone in an unusual clinical situation involving reproductive planning should discuss it with a specialist.

Cost and generic availability

Generic galantamine, both ER and IR, has been available for years and is inexpensive. The brand name Razadyne is still around but generally unnecessary. Insurance coverage is straightforward in most plans.

Common questions

How is galantamine different from donepezil? Both raise acetylcholine by blocking the enzyme that breaks it down. Galantamine adds a second mechanism at nicotinic receptors, which is a plausible but not proven advantage. Head-to-head efficacy is similar. The choice usually comes down to tolerability and dosing convenience.

Why with food? Empty-stomach dosing meaningfully worsens nausea. Taking it with a full meal makes a real difference in tolerability.

What if we've missed several days? Call the prescriber before restarting. The dose usually needs to be walked back up from the starting dose. Restarting at the maintenance dose after a break can cause severe vomiting.

How long until we know if it's working? Give it 3 to 6 months at a stable target dose. Watch for slower decline rather than dramatic improvement.

Questions to ask your prescriber

• What are we hoping to see, and how will we know it's working?
• How will we track weight and heart rate?
• Are any of the current medications a problem to combine with galantamine?
• If GI side effects come up at a dose step, what's the plan?
• How will we know when it's time to move up, or time to stop?

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes, and current as of June 8, 2026.

• U.S. Food and Drug Administration. Galantamine (Razadyne) prescribing information.
• DailyMed, U.S. National Library of Medicine. Galantamine label.
• MedlinePlus, U.S. National Library of Medicine. Galantamine.
• National Institute of Mental Health. Mental health medications.
• American Academy of Neurology. Practice guideline update on pharmacologic treatment of dementia.
• American Psychiatric Association. Practice guideline on the use of antipsychotics and cognitive enhancers in dementia.